一 | Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。 本网讯 特约记者刘雨晴报道 随着汛期的到来，降雨逐渐增多，兴城市应急管理局着眼“想在前、做在前、准备在前”，精心做好防汛抢险物资储备工作，全力保障人民群众生命财产安全。 7月11日，在兴城市应急管理局防汛救灾物资储备库里，救生衣、棉被、帐篷等防汛物资按照不同类别有序堆放在指定区域，工作人员正忙着清点统计物资数量，确保及时记录更新物资调拨使用。目前，兴城市应急管理局共设置防汛物资储备库8处，在去年基础上，新购入救生衣50件、组合式防洪板40块、雨衣80件、漂浮救生绳30套等，各类物资储备充足，质量完好，随时可用。
Current article:http://www.choumaimuwogenkuzhainuan.bond/oun/20260826/8200.doc
Published on:12:33:13
微信
移动端
